Histologically confirmed HT is associated with a significantly higher risk of PTC, due primarily to the higher serum TSH concentrations resulting from the tendency to hypothyroidism in HT. Autoimmunity is another independent risk factor for PTC but may be associated with a better prognosis.
Overgrazing and climate warming may be important drivers of alpine rangeland degradation in the Qinghai-Tibetan Plateau (QTP). In this study, the effects of grazing and experimental warming on the vegetation of cultivated grasslands, alpine steppe and alpine meadows on the QTP were investigated. The three treatments were a control, a warming treatment and a grazing treatment and were replicated three times on each vegetation type. The warming treatment was applied using fibreglass open-top chambers and the grazing treatment was continuous grazing by yaks at a moderately high stocking rate. Both grazing and warming negatively affected vegetation cover. Grazing reduced vegetation height while warming increased vegetation height. Grazing increased but warming reduced plant diversity. Grazing decreased and warming increased the aboveground plant biomass. Grazing increased the preferred forage species in native rangelands (alpine steppe and alpine meadow), while warming increased the preferred forage species in the cultivated grassland. Grazing reduced the vegetation living state (VLS) of all three alpine grasslands by nearly 70%, while warming reduced the VLS of the cultivated grassland and the alpine steppe by 32% and 56%, respectively, and promoted the VLS of the alpine meadow by 20.5%. It was concluded that overgrazing was the main driver of change to the alpine grassland vegetation on the QTP. The findings suggest that grazing regimes should be adapted in order for them to be sustainable in a warmer future.
Previous studies have suggested that immune system development and weaning stress are closely related to the maturation of gut microbiota. The early-life period is a "window of opportunity" for microbial colonization, which potentially has a critical impact on the development of the immune system. Fecal microbiota transplantation (FMT) and probiotics are often used to regulate gut microbial colonization. This study aims to test whether early intervention with FMT using fecal microbiota from gestation sows combined with Clostridium butyricum and Saccharomyces boulardii (FMT-CS) administration could promote the maturation of gut microbiota and development of immune system in piglets. Piglets were assigned to control (n = 84) and FMT-CS treatment (n = 106), which were treated with placebo and bacterial suspension during the first three days after birth, respectively. By 16S rRNA gene sequencing, we found that FMT-CS increased the α-diversity and reduced the unweighted UniFrac distances of the OTU community. Besides, FMT-CS increased the relative abundance of beneficial bacteria, while decreasing that of opportunistic pathogens. FMT-CS also enhanced the relative abundance of genes related to cofactors and vitamin, energy, and amino acid metabolisms during the early-life period. ELISA analysis revealed that FMT-CS gave rise to the plasma concentrations of IL-23, IL-17, and IL-22, as well as the plasma levels of anti-M.hyo and anti-PCV2 antibodies. Furthermore, the FMT-CS-treated piglets showed decreases in inflammation levels and oxidative stress injury, and improvement of intestinal barrier function after weaning as well. Taken together, our results suggest that early-life intervention with FMT-CS could promote the development of innate and adaptive immune system and vaccine efficacy, and subsequently alleviate weaning stress through promoting the maturation of gut microbiota in piglets.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.